Skip to content

Multi omics study of tongue coating in neurodegenerative diseases: potential biomarker discovery based on HPLC/MS technology

Multi omics study of tongue coating in neurodegenerative diseases: potential biomarker discovery based on HPLC/MS technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091883
Enrollment
Unknown
Registered
2024-11-05
Start date
2024-11-15
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodegenerative diseases

Interventions

Observation group (with Parkinson's disease):none
Observation group (with Alzheimers disease):none

Sponsors

Shanghai Genaral Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: PD diagnostic criteria: Parkinson's disease group meets internationally recognized diagnostic criteria: MDS clinical diagnostic criteria for Parkinson's dise30 Inclusion criteria for PD group: (1) Meet the diagnostic criteria for PD; (2) Age>18 years old; (3) Voluntarily participate in this study and sign the informed consent form. (4) No other systemic diseases, such as tumors, infectious diseases, digestive system diseases, etc. Inclusion criteria for CON group: (1) Confirmation of absence of neurodegenerative diseases; (2) Age>18 years old; (3) Voluntarily participate in this study and sign the informed consent form. (4) No other systemic diseases, such as tumors, infectious diseases, digestive system diseases, etc.

Exclusion criteria

Exclusion criteria: Two exclusion criteria: (1) Use of drugs that affect the tongue coating status within the two weeks prior to sampling (such as traditional Chinese medicine, antibiotics, antifungal drugs, etc.); (2) Suffering from diseases that affect the state of tongue coating (such as acute upper respiratory tract infection, oral ulcers, glossitis, etc.); (3) Accompanied by major diseases such as liver and kidney dysfunction, severe infections, malignant tumors, etc.

Design outcomes

Primary

MeasureTime frame
Peak area of non targeted metabolites;

Secondary

MeasureTime frame
Tongue coating index;

Countries

China

Contacts

Public ContactFan Guorong

Shanghai Genaral Hospital

guorfan@163.com+86 133 0177 7863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026